Aml Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Quizartinib added to induction and consolidation chemotherapy and continued as a single agent for up to 36 cycles improves the overall survival of adults with FLT3 ITD mutated AML.

North carolinaUnited statesHarryp erbaDivision of hematologic malignanciesMeeting of the society hematologic oncologyLeukemia programDuke university health system in durhamCurrent landscapeAnnual meetingHematologic oncologyHematologic malignanciesCellular therapyDuke university health systemUnited states thereforeFirst studySoho annual meeting